Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China (vol 13, 237, 2015)

被引：3

作者：

Richeldi, Luca ^{[1
]}

Rubin, Adalberto Sperb ^{[2
]}

Avdeev, Sergey ^{[3
]}

Udwadia, Zarir F. ^{[4
,5
]}

Xu, Zuo Jun ^{[6
]}

机构：

[1] Univ Hosp Southampton NHS Fdn Trust, Southampton Resp Biomed Res Unit, Mailpoint 813,LE75 E Level,South Acad Block, Southampton SO16 6YD, Hants, England

[2] Fed Univ Porto Alegre UFCSPA, Pulm Dept, Santa Casa Hosp, Porto Alegre, RS, Brazil

[3] Pulmonol Res Inst, Clin Dept, 32,11th Parkovaya Str, Moscow 105077, Russia

[4] Hinduja Hosp & Res Ctr, Mumbai 400016, Maharashtra, India

[5] Breach Candy Hosp, B Desai Rd, Mumbai 400026, Maharashtra, India

[6] Chinese Acad Med Sci & Peking Union Med Coll, Dept Resp Med, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China

来源：

BMC MEDICINE | 2021年 / 19卷 / 01期

关键词：

D O I：

10.1186/s12916-021-02111-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：1

共 36 条

[21] Relevance of RNA N6-methyladenosine regulators for pulmonary fibrosis: Implications for chronic hypersensitivity pneumonitis and idiopathic pulmonary fibrosis (vol 13, 939175, 2022)
Zhou, Yiyi
Fang, Chen
Sun, Qinying
Dong, Yuchao
FRONTIERS IN GENETICS, 2022, 13
[22] Country Risk Ratings and Stock Market Returns in Brazil, Russia, India, and China (BRICS) Countries: A Nonlinear Dynamic Approach
Ben Nasr, Adnen
Cunado, Juncal
Demirer, Riza
Gupta, Rangan
RISKS, 2018, 6 (03):
[23] Pirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis (vol 10, e0136160, 2015)
Aravena, Carlos
Labarca, Gonzalo
Venegas, Carmen
Arenas, Alex
Rada, Gabriel
PLOS ONE, 2015, 10 (10):
[24] Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis (vol 10, e0127771, 2015)
Donahoe, Michael
Valentine, Vincent G.
Chien, Nydia
Gibson, Kevin F.
Raval, Jay S.
Saul, Melissa
Xue, Jianmin
Zhang, Yingze
Duncan, Steven R.
PLOS ONE, 2015, 10 (07):
[25] Empirical analysis of the environmental and energy policies in some developing countries using widely employed macroeconomic indicators: the cases of Brazil, China and India
Focacci, A
ENERGY POLICY, 2005, 33 (04) : 543 - 554
[26] Cellular senescence-like features of lung fibroblasts derived from idiopathic pulmonary fibrosis patients (vol 7, pg 664, 2015)
Yanai, Hagai
Shteinberg, Albert
Porat, Ziv
Budovsky, Arie
Braiman, Alex
Ziesche, Rolf
Fraifeld, Vadim E.
AGING-US, 2015, 7 (11): : 1022 - 1022
[27] Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis (vol 24, pg 58, 2015)
Cottin, Vincent
Maher, Toby
EUROPEAN RESPIRATORY REVIEW, 2015, 24 (137): : 545 - 545
[28] BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis (vol 13, 838449, 2022)
Herrmann, Franziska Elena
Hesslinger, Christian
Wollin, Lutz
Nickolaus, Peter
FRONTIERS IN PHARMACOLOGY, 2023, 14
[29] Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis (vol 13, 993567, 2022)
Huang, Guirui
Huang, Shuaiyang
Cui, Hongsheng
FRONTIERS IN PHARMACOLOGY, 2022, 13
[30] Modelling and forecasting CO2 emissions in the BRICS (Brazil, Russia, India, China, and South Africa) countries using a novel multi-variable grey model
Wu, Lifeng
Liu, Sifeng
Liu, Dinglin
Fang, Zhigeng
Xu, Haiyan
ENERGY, 2015, 79 : 489 - 495

← 1 2 3 4 →